Wird geladen...
ATIM-09. RETROSPECTIVE STUDY OF NIVOLUMAB FOR PATIENTS WITH RECURRENT HIGH GRADE GLIOMAS
BACKGROUND: Patients with recurrent primary CNS malignancies have limited treatment options and poor clinical outcome. High grade gliomas use the PD-1 pathway to evade immune responses. Checkpoint inhibitors have recently demonstrated safety and encouraging clinical activity in patients with refract...
Gespeichert in:
| Veröffentlicht in: | Neuro Oncol |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5693046/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.105 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|